Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2015-10-31
2016-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Resistance and Endurance Training on Synthesis of Individual Muscle Proteins in Young and Older Adults
NCT01489930
Identifying Therapeutic Targets of Accelerated Sarcopenia
NCT03118050
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults
NCT02442479
Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training
NCT02142855
Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and Women
NCT03888040
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise
Determining the effect of 12 weeks of resistance training exercise on the response of muscle amino acid sensing
Exercise
Progressive resistance exercise training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Progressive resistance exercise training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable body weight for at least 1 year
* Ability to sign consent form:
Exclusion Criteria
* Physical dependence or frailty (impairment in the Activities of Daily Living (ADL), history of falls (\>2/year), or \>5% weight loss in the past year)
* Significant heart, liver, kidney, blood, or respiratory disease
* Peripheral vascular disease
* Diabetes mellitus or other untreated endocrine disease
* Active cancer
* Acute infectious disease or history of chronic infections
* Recent (within 3 months) treatment with anabolic steroids, or prolonged systemic corticosteroids.
* Alcohol or drug abuse
* Tobacco use (smoking or chewing)
* Malnutrition (BMI \< 18.5 kg/sq meter)
* Obesity (BMI \> 30 kg/sq meter)
65 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
The University of Texas Medical Branch, Galveston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Blake B Rasmussen, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Texas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UTMB
Galveston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Moro T, Brightwell CR, Deer RR, Graber TG, Galvan E, Fry CS, Volpi E, Rasmussen BB. Muscle Protein Anabolic Resistance to Essential Amino Acids Does Not Occur in Healthy Older Adults Before or After Resistance Exercise Training. J Nutr. 2018 Jun 1;148(6):900-909. doi: 10.1093/jn/nxy064.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-0226
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.